Erika Seth Davies

Erika Seth Davies is the CEO of Rhia Ventures, which aims to transform the U.S. market for sexual, reproductive, and maternal health into a vibrant and equitable one through its impact investing, ecosystem building, corporate engagement, and narrative change work. She is a seasoned leader with more than 20 years of experience in development and… Continue reading Erika Seth Davies

Jenny Yip

Jenny is currently a Managing Partner at Adjuvant Capital, a life sciences investment fund dedicated to mid- to late-stage research and development of products addressing significant global health challenges affecting lower- and middle-income countries.  Adjuvant’s portfolio spans across drugs, vaccines, medical devices and diagnostics for high-burden infectious disease, sexual and reproductive health.  Jenny currently serves… Continue reading Jenny Yip

Amy Raimundo

Amy Belt Raimundo is Managing Director of Kaiser Permanente Ventures. She is also currently an Independent Board Director at NuVasive Inc (NASDAQ: NUVA). Amy has a 15 year history of venture investing in medtech, diagnostics, healthcare information technology and digitized services including with Advanced Technology Ventures, Covidien Ventures and Convey Capital. In those roles, she… Continue reading Amy Raimundo

Anula Jayasuriya, MD, PhD

Anula Jayasuriya is a successful private equity executive and venture capitalist whose background combines deep business, scientific and medical knowledge with broad clinical, industry, entrepreneurial, and investment experience. Anula was among the first investors to recognize the untapped opportunity in the unmet needs in women’s health (WH). Integrating her passion with her investing expertise, in… Continue reading Anula Jayasuriya, MD, PhD

Stacy Feld, JD

Stacy is Regional Head of Johnson & Johnson Innovation, West North America and is based in Brisbane, California. In this role, she leads a team of scientific and business leaders to build, advance, and manage a portfolio of co-investments and collaborations spanning the pharmaceutical, consumer health and medical device sectors. Stacy is also responsible for… Continue reading Stacy Feld, JD

Janice Bourque

Janice Bourque is Managing Director of Life Sciences for Hercules Capital, a premier specialty public life science companies at all stages of development with $16 billion committed to over 600 life science, technology and renewable energy companies. Deal sizes range from $10m-$300m and included in her portfolio are BIND Bioscience, BioMx, Brickell, Cempra Pharmaceuticals, Codiak… Continue reading Janice Bourque